Pharmaceutical Business review

Wright Medical to acquire Inbone Technologies

The acquisition consists of an initial cash payment of $24 million, guaranteed minimum future payments of $3.7 million and potential additional cash payments based upon the future operational and financial performance of the company.

Gary Henley, Wright’s president and CEO, said: “The Inbone acquisition represents a key milestone in our effort to become the leading supplier of foot and ankle surgical products. The addition of Inbone’s next-generation total ankle will no doubt provide significant leverage to our product portfolio and add fuel to support and expand our focused foot and ankle sales force.”